Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astellas, Entrada, Horizon, Idorsia, Invectys, Iveric, Kira, Maia, Merck & Co., Mitsubishi Tanabe, NS, Seagen, Skye.